Search
for
Sort by
Research 31–60 of 1000+
- Injectable Biomaterials for Dental Tissue Regeneration
- Delivery systems in nanocosmeceuticals
- Alginate-Based Cryogels for Combined Chemo/Photothermal Antibacterial Therapy and Rapid Hemostasis
- Biological properties of polycaprolactone and barium titanate composite in biomedical applications
- Determination of the pH Gradient in Hair Follicles of Human Volunteers Using pH-Sensitive Melamine Formaldehyde-Pyranine Nile Blue Microparticles
- Recent Tissue Engineering Approaches to Mimicking the Extracellular Matrix Structure for Skin Regeneration
- Advanced 3D/4D Bioprinting of Flexible Conductive Materials for Regenerative Medicine: From Bioinspired Design to Intelligent Regeneration
- Nanofiber Scaffolds as Drug Delivery Systems Promoting Wound Healing
- The Influence of Stinging Nettle (Urtica dioica L.) Infusions on the Techno-Functionality of k-Carrageenan Hydrogels
- Succinic Acid in Cosmetics and Aesthetic Dermatology: Biological Roles and Applications
- Ultrasound-responsive hydrogel with ROS scavenging and NO controllable release capabilities for accelerated healing of diabetic wounds
- Functionalized Bacterial Cellulose for Medical Tissue Engineering
- SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
- A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia.
- Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Alopecia Universalis Treated with Ayurveda Protocol and Assessed by SALT (Severity of Alopecia Tool) - A Case Report
- Complete responses and SALT zero scores in alopecia areata: not the same
- Generative Artificial Intelligence Tools: Evaluating Ways to Automate Your SALT ( GATEWAYS ) Scoring of Alopecia Areata
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation
- rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation
- Generative Artificial Intelligence Tools: Evaluating Ways to Automate Your SALT (GATEWAYS) Scoring of Alopecia Areata
- SALT Score Cards: Facilitating SALT Score Calculation in Alopecia Areata
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial